Genetic Polymorphisms of Angiotensin Converting Enzyme (I/D) and Endothelial Nitric Oxide Synthase (T(-788)C) Genes in Japanese Patients with Myocardial Infarction

Genetic Polymorphisms of Angiotensin Converting Enzyme (I/D) and Endothelial Nitric Oxide Synthase (T(-788)C) Genes in Japanese Patients with Myocardial Infarction -

[1]  J. Vermylen,et al.  The ATP-Gated P2X1 Ion Channel Acts as a Positive Regulator of Platelet Responses to Collagen , 2001, Thrombosis and Haemostasis.

[2]  C. Gachet,et al.  Differential Involvement of the P2Y1 and P2YT Receptors in the Morphological Changes of Platelet Aggregation , 2001, Thrombosis and Haemostasis.

[3]  T. Ogihara,et al.  T+31C Polymorphism of Angiotensinogen Gene and Essential Hypertension , 2001, Hypertension.

[4]  C. Brearley,et al.  Platelet Shape Change Evoked by Selective Activation of P2X1 Purinoceptors with α,β-Methylene ATP , 2001, Thrombosis and Haemostasis.

[5]  R. Evans,et al.  ADP is not an agonist at P2X1 receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets , 2000, British journal of pharmacology.

[6]  J. Vermylen,et al.  A Natural Dominant Negative P2X1 Receptor Due to Deletion of a Single Amino Acid Residue* , 2000, The Journal of Biological Chemistry.

[7]  G. Burnstock,et al.  Activity of novel adenine nucleotide derivatives as agonists and antagonists at recombinant rat P2X receptors , 2000, Drug development research.

[8]  T. Ogihara,et al.  Human prostacyclin synthase gene and hypertension : the Suita Study. , 1999, Circulation.

[9]  Sarah Parish,et al.  Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls , 1999, The Lancet.

[10]  C. Gachet,et al.  ADP receptors and clinical bleeding disorders. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[11]  K. Nakao,et al.  T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. , 1999, Circulation.

[12]  Herrmann,et al.  Polymorphisms of the endothelial nitric oxide synthase gene — no consistent association with myocardial infarction in the ECTIM study , 1999, European journal of clinical investigation.

[13]  G Burnstock,et al.  Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.

[14]  T. K. Harden,et al.  Identification of competitive antagonists of the P2Y1 receptor. , 1996, Molecular pharmacology.

[15]  P. Stanssens,et al.  An echistatin‐like Arg‐Gly‐Asp (RGD)‐containing sequence in the heavy chain CDR3 of a murine monoclonal antibody that inhibits human platelet glycoprotein IIb/IIIa function , 1994, British journal of haematology.

[16]  Philippe Amouyel,et al.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.